200+ total transactions representing $90B+ in aggregate value — 22 tracked below spanning 2018–2026 · 4 industries
Exclusive financial advisor to ImmunoPrecise Antibodies on its divestiture of IPA Europe subsidiary to AVS Bio.
Sell-side advisory on the acquisition of a healthcare services company.
Exclusive advisor to The Emergency Center of Arizona on its acquisition by Emergency Care Partners.
Exclusive financial advisor to LUX Infusion in its sale to BioMatrix Specialty Infusion Pharmacy, a portfolio company of Frazier Healthcare Partners.
Exclusive financial advisor to Trilogy Home Healthcare, a portfolio company of Kinderhook Industries, on its sale to CenterWell Home Health, a subsidiary of Humana (NYSE: HUM). Founded in 2016 and headquartered in West Palm Beach, FL, Trilogy was one of the nation's largest Medicare-licensed home health providers with 11 locations serving over 4,700 patients.
Exclusive financial advisor to Superior Health Holdings, a portfolio company of Sopris Capital, on its sale to Renovus Capital Partners.
Exclusive financial advisor to Bridges Inc. in its sale to Proud Moments ABA, a leading ABA (applied behavior analysis) services platform.
Financial advisor to Preferred Home Health Care & Nursing Services, a portfolio company of Webster Equity Partners, on its acquisition by Care Options for Kids.
Financial advisor to Infusion Center of Pennsylvania on its acquisition by Vivo Infusion, a portfolio company of InTandem Capital Partners.
Financial advisor to Tennessee Retina on its acquisition by Retina Consultants of America.
Co-advisor to Brookhaven NeuroRehabilitation Network in its sale to National Health Investors and Vizion Health. BNN provides neurobehavioral rehabilitation services through its primary inpatient facility and affiliate locations in Tulsa, OK.
Financial advisor to Comfort Care Home Health & Hospice on its $34.5M acquisition by Aveanna Healthcare, a leading post-acute care platform.
Exclusive financial advisor on the acquisition of a consulting firm.
Financial advisor to THL Partners on its acquisition of Headlands Research from KKR, a clinical research organization.
Sell-side advisory on the acquisition of a pharmaceutical communications and services firm.
Exclusive financial advisor to Evolution Research Group, a clinical research site services platform, on its growth investment from Linden Capital Partners. ERG facilitated improved drug development services for biopharmaceutical and CRO clients.
Sell-side advisory on the acquisition of a healthcare software platform.
Exclusive sell-side advisor on the acquisition of a healthcare content and influencer platform by HealthCentral.